163 related articles for article (PubMed ID: 20036234)
1. Involvement of 1,25D3-MARRS (membrane associated, rapid response steroid-binding), a novel vitamin D receptor, in growth inhibition of breast cancer cells.
Richard CL; Farach-Carson MC; Rohe B; Nemere I; Meckling KA
Exp Cell Res; 2010 Mar; 316(5):695-703. PubMed ID: 20036234
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS)-binding protein in rat IEC-6 cells.
Rohe B; Safford SE; Nemere I; Farach-Carson MC
Steroids; 2005; 70(5-7):458-63. PubMed ID: 15862831
[TBL] [Abstract][Full Text] [Related]
3. Modulation of 1alpha,25-dihydroxyvitamin D3-membrane associated, rapid response steroid binding protein expression in mouse odontoblasts by 1alpha,25-(OH)2D3.
Teillaud C; Nemere I; Boukhobza F; Mathiot C; Conan N; Oboeuf M; Hotton D; Macdougall M; Berdal A
J Cell Biochem; 2005 Jan; 94(1):139-52. PubMed ID: 15523675
[TBL] [Abstract][Full Text] [Related]
4. Expression of a 1,25-dihydroxyvitamin D3 membrane-associated rapid-response steroid binding protein during human tooth and bone development and biomineralization.
Mesbah M; Nemere I; Papagerakis P; Nefussi JR; Orestes-Cardoso S; Nessmann C; Berdal A
J Bone Miner Res; 2002 Sep; 17(9):1588-96. PubMed ID: 12211428
[TBL] [Abstract][Full Text] [Related]
5. Actin and Keratin are Binding Partners of the 1,25D
LeBlanc T; Nemere L
Immunol Endocr Metab Agents Med Chem; 2014 Aug; 14(2):55-66. PubMed ID: 26029286
[TBL] [Abstract][Full Text] [Related]
6. Membrane receptors for vitamin D steroid hormones: potential new drug targets.
Farach-Carson MC; Nemere I
Curr Drug Targets; 2003 Jan; 4(1):67-76. PubMed ID: 12528991
[TBL] [Abstract][Full Text] [Related]
7. The ERp57/GRp58/1,25D3-MARRS receptor: multiple functional roles in diverse cell systems.
Khanal RC; Nemere I
Curr Med Chem; 2007; 14(10):1087-93. PubMed ID: 17456022
[TBL] [Abstract][Full Text] [Related]
8. Regulation of expression of 1,25D3-MARRS/ERp57/PDIA3 in rat IEC-6 cells by TGF beta and 1,25(OH)2D3.
Rohe B; Safford SE; Nemere I; Farach-Carson MC
Steroids; 2007 Feb; 72(2):144-50. PubMed ID: 17188725
[TBL] [Abstract][Full Text] [Related]
9. Ribozyme knockdown functionally links a 1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells.
Nemere I; Farach-Carson MC; Rohe B; Sterling TM; Norman AW; Boyan BD; Safford SE
Proc Natl Acad Sci U S A; 2004 May; 101(19):7392-7. PubMed ID: 15123837
[TBL] [Abstract][Full Text] [Related]
10. Membrane receptors for vitamin D metabolites.
Khanal R; Nemere I
Crit Rev Eukaryot Gene Expr; 2007; 17(1):31-47. PubMed ID: 17341182
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a vitamin D3-resistant MCF-7 cell line.
Narvaez CJ; Vanweelden K; Byrne I; Welsh J
Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
[TBL] [Abstract][Full Text] [Related]
12. Effect of growth and maturation on membrane-initiated actions of 1,25-dihydroxyvitamin D3-II: calcium transport, receptor kinetics, and signal transduction in intestine of female chickens.
Larsson B; Nemere I
J Cell Biochem; 2003 Dec; 90(5):901-13. PubMed ID: 14624450
[TBL] [Abstract][Full Text] [Related]
13. The 1,25D3-MARRS protein: contribution to steroid stimulated calcium uptake in chicks and rats.
Nemere I
Steroids; 2005; 70(5-7):455-7. PubMed ID: 15862830
[TBL] [Abstract][Full Text] [Related]
14. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Wietzke JA; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
[TBL] [Abstract][Full Text] [Related]
15. Putative membrane receptor for 1,25(OH)2 vitamin D3 in human mineralized tissues during prenatal development.
Berdal A; Mesbah M; Papagerakis P; Nemere I
Connect Tissue Res; 2003; 44 Suppl 1():136-40. PubMed ID: 12952187
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of the 1,25D3-MARRS receptor (ERp57/PDIA3) on murine mammary gland development depend on the vitamin D3 dose.
Wilkin AM; Sullivan R; Trinh T; Edson M; Kozlowski B; Meckling KA
Steroids; 2020 Jun; 158():108621. PubMed ID: 32119872
[TBL] [Abstract][Full Text] [Related]
18. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
19. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
[TBL] [Abstract][Full Text] [Related]
20. Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORĪ± and RORĪ³.
Slominski AT; Kim TK; Hobrath JV; Oak ASW; Tang EKY; Tieu EW; Li W; Tuckey RC; Jetten AM
J Steroid Biochem Mol Biol; 2017 Oct; 173():42-56. PubMed ID: 27693422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
